Nonalcoholic steatohepatitis (NASH) is considered the progressive form of nonalcoholic fatty
liver disease (NAFLD) and is characterized by liver steatosis, inflammation, hepatocellular …

Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and
more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and …

Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of diseases, including
simple steatosis, nonalcoholic steatohepatitis (NASH), liver cirrhosis and hepatocellular …

Whereas in most cases a fatty liver remains free of inflammation, 10%‐20% of patients who
have fatty liver develop inflammation and fibrosis (nonalcoholic steatohepatitis [NASH]) …

Accumulating evidence links obesity with low-grade inflammation which may originate from
adipose tissue that secretes a plethora of pro-and anti-inflammatory cytokines termed …

Background. It has been suggested that visfatin, which is an adipocytokine, exhibits
proinflammatory properties and is associated with insulin resistance. Insulin resistance and …

Non-alcoholic fatty liver disease (NAFLD) refers to the accumulation of hepatic steatosis not
due to excess alcohol consumption. The prevalence of NAFLD is up to 30% in developed …

Since its discovery twenty-five years ago, the fat-derived hormone leptin has provided a
revolutionary framework for studying the physiological role of adipose tissue as an …

Non-alcoholic fatty liver disease (NAFLD), which affects about a quarter of the global
population, poses a substantial health and economic burden in all countries, yet there is no …

Obesity, diabetes, insulin resistance, sedentary lifestyle, and Western diet are the key factors
underlying non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases …